Latest Press Releases

• Early results from a trial of active surveillance for low-risk DCIS are ‘reassuring’27 March 2026
  Barcelona, Spain: Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as ‘reassuring’ in a presentation to the 15th European Breast Cancer Conference (EBCC15) in Barcelona. People diagnosed… Read more: Early results from a trial of active surveillance for low-risk DCIS are ‘reassuring’
• Tumour DNA circulating in patients’ blood after pre-surgery treatments predicts whether breast cancer will return27 March 2026
  Barcelona, Spain: Fragments of tumour DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received treatments prior to… Read more: Tumour DNA circulating in patients’ blood after pre-surgery treatments predicts whether breast cancer will return
• Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive26 March 2026
  Barcelona, Spain: Results from the OASIS 4 clinical trial last year showed that a new drug, elinzanetant, relieved hot flushes and night sweats that can occur because of the menopause or because of hormone treatment for… Read more: Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive
• Radiotherapy rather than surgery may help reduce risk of lymphoedema in patients with breast cancer: results from pilot study26 March 2026
  Barcelona, Spain: Patients with breast cancer may be able to avoid lymphoedema, which can occur after surgery to remove lymph nodes in the armpit (the axilla), by having radiotherapy instead. New findings, presented at the 15th… Read more: Radiotherapy rather than surgery may help reduce risk of lymphoedema in patients with breast cancer: results from pilot study